Literature DB >> 2528454

Comparative in vitro activity of norfloxacin against resistant Neisseria gonorrhoeae.

S Ponticas1, D L Shungu, C J Gill.   

Abstract

The in vitro activity of seven antibiotics against 52 isolates of Neisseria gonorrhoeae was determined. Against penicillinase-producing Neisseria gonorrhoeae, ceftriaxone was the most active agent (MIC90 0.015 micrograms/ml), followed by ceftizoxime and norfloxacin (MIC90 0.03-0.125 micrograms/ml). Against spectinomycin-resistant Neisseria gonorrhoeae, the most active agents were ceftizoxime, ceftriaxone and norfloxacin (MIC90 0.015-0.125 micrograms/ml). Ceftizoxime, ceftriaxone and norfloxacin were also the most active agents against tetracycline-resistant Neisseria gonorrhoeae (MIC90 0.06-0.125 micrograms/ml). Overall, the rank order of activity from the most to the least active agent was as follows: ceftizoxime (MIC90 0.015 micrograms/ml); ceftriaxone (MIC90 0.06 micrograms/ml); norfloxacin (MIC90 0.125 micrograms/ml); cefoxitin (MIC90 2 micrograms/ml); tetracycline (MIC90 8 micrograms/ml); penicillin (MIC90 greater than 8 micrograms/ml); and spectinomycin (MIC90 greater than 128 micrograms/ml).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2528454     DOI: 10.1007/bf01968143

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

1.  Antibiotic-resistant strains of Neisseria gonorrhoeae. Policy guidelines for detection, management, and control.

Authors: 
Journal:  MMWR Suppl       Date:  1987-09-11

2.  Gonococcal resistance to antibiotics.

Authors:  C S Easmon
Journal:  J Antimicrob Chemother       Date:  1985-10       Impact factor: 5.790

3.  In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.

Authors:  M Peeters; E Van Dyck; P Piot
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

4.  Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae.

Authors:  S W Berg; M E Kilpatrick; W O Harrison; J A McCutchan
Journal:  N Engl J Med       Date:  1979-09-06       Impact factor: 91.245

5.  Norfloxacin versus thiamphenicol for treatment of uncomplicated gonorrhea in Rwanda.

Authors:  J Bogaerts; W Martinez Tello; L Verbist; P Piot; J Vandepitte
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

6.  Genetic analysis of drug resistance in Neisseria gonorrhoeae: production of increased resistance by the combination of two antibiotic resistance loci.

Authors:  T W Maier; L Zubrzycki; M B Coyle; M Chila; P Warner
Journal:  J Bacteriol       Date:  1975-11       Impact factor: 3.490

7.  Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin.

Authors:  S R Crider; S D Colby; L K Miller; W O Harrison; S B Kerbs; S W Berg
Journal:  N Engl J Med       Date:  1984-07-19       Impact factor: 91.245

8.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

9.  Activities of new quinoline derivatives against genital pathogens.

Authors:  J Aznar; M C Caballero; M C Lozano; C de Miguel; J C Palomares; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.